OPXA Stock Quote and Technical Analysis
| Portfolios | Markets | Resources |
|
|
|
Opexa Therapeutics, Inc. (OPXA) ▼ 1.67 (-0.07) -4.02% Open: 1.67 High: 1.74 Low: 1.65 Afterhours: N/A - N/A Volume: 168247 5/17/2013 3:59pm |
Interactive Chart |
| EPS: -1.544 (Current Year Estimated: 0.00) Dividend: N/A P/E: N/A Technicals: 52 Week Range: 1.07 - 5.19 50 Day Moving Average: 2.0023 200 Day Moving Average: 1.9392 Pivot Point (Next Trading Session): 1.69 Login or signup free to Add "OPXA" to your portfolio Resources: |
| News: Q1 2013 OPEXA THERAPEUTICS INC Earnings Release - Before Market Open Tue, 14 May 2013 11:07:09 GMT Opexa Therapeutics Reports First Quarter 2013 Financial Results and Provides Corporate Update Tue, 14 May 2013 10:00:00 GMT [Business Wire] - Opexa Therapeutics, Inc. , a leader in developing a patient specific T-cell immunotherapy for multiple sclerosis , today reported financial results for the quarte OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report Tue, 14 May 2013 03:07:44 GMT OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Tue, 14 May 2013 03:07:44 GMT Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2013 Financial Results Fri, 10 May 2013 13:00:00 GMT [Business Wire] - Opexa Therapeutics, Inc. , a leader in developing a patient specific T-cell immunotherapy for multiple sclerosis , today announced that the company will report financial results for the three months ended March 31, 2013, before the opening of trading on Tuesday, May 14th. The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Host 2nd International Vatican Adult Stem Cell Conference Thu, 11 Apr 2013 12:36:21 GMT [GlobeNewswire] - NEW YORK -- The Stem for Life Foundation, NeoStem, Inc. (NYSE MKT:NBS), The Pontifical Council for Culture, and STOQ International today announced the beginning of its historic three day event, The Second ... OPEXA THERAPEUTICS, INC. Financials Thu, 04 Apr 2013 17:04:15 GMT Opexa Therapeutics to Present at the Regenerative Medicine - A Fundamental Shift in Science & Culture Conference Thu, 04 Apr 2013 12:30:00 GMT [Business Wire] - Opexa Therapeutics, Inc. , a biotechnology company developing Tcelnaâ„¢, a novel T-cell therapy for multiple sclerosis , today announced that Neil K. Warma, Preside 04/01/2013 - Opexa Therapeutics Announces Changes to Senior Management Team Mon, 01 Apr 2013 21:00:21 GMT [at noodls] - Opexa Therapeutics Announces Changes to Senior Management Team THE WOODLANDS, Texas (April 01, 2013) - Opexa Therapeutics, Inc. (NASDAQ: OPXA), a leader in developing a patient specific T-cell immunotherapy ... 03/28/2013 - Opexa Therapeutics Reports Year End 2012 Financial Results and Provides Corporate Update Mon, 01 Apr 2013 17:00:55 GMT [at noodls] - Opexa Therapeutics Reports Year End 2012 Financial Results and Provides Corporate Update THE WOODLANDS, Texas (March 28, 2013) - Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing ... Opexa Therapeutics Announces Changes to Senior Management Team Mon, 01 Apr 2013 13:00:00 GMT [Business Wire] - Opexa Therapeutics, Inc. , a leader in developing a patient specific T-cell immunotherapy for multiple sclerosis is pleased to announce the strengthening of its management team through the appointment of several key individuals. OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State Mon, 01 Apr 2013 06:19:08 GMT OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Fri, 29 Mar 2013 06:15:00 GMT Opexa Therapeutics Reports Year End 2012 Financial Results and Provides Corporate Update Thu, 28 Mar 2013 23:00:00 GMT [Business Wire] - Opexa Therapeutics, Inc. , a biotechnology company developing a novel T-cell therapy for multiple sclerosis , today reported financial results for the year ended Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here Wed, 27 Mar 2013 01:02:48 GMT Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors Tue, 26 Mar 2013 13:01:00 GMT The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference Fri, 22 Mar 2013 17:07:09 GMT [at noodls] - Highlights Include Keynote by Nobel Prize Winner, Dr. John Gurdon New York, March 21, 2013 -- The Stem for Life Foundation, NeoStem, Inc. (NYSE MKT:NBS), The Pontifical Council for Culture, and STOQ International ... The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference Fri, 22 Mar 2013 12:57:26 GMT [GlobeNewswire] - NEW YORK -- The Stem for Life Foundation, NeoStem, Inc. (NYSE MKT:NBS), The Pontifical Council for Culture, and STOQ International today released details on the program of The Second International Vatican ... Opexa Therapeutics Poised For Breakout Tue, 12 Mar 2013 14:39:25 GMT 03/04/2013 - Opexa Therapeutics to Present at the 6th Annual European Life Science CEO Forum Mon, 04 Mar 2013 20:26:02 GMT [at noodls] - Opexa Therapeutics to Present at the 6th Annual European Life Science CEO Forum THE WOODLANDS, Texas (March 4, 2013) - Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelnaâ„¢, a novel T-cell ... All Company News is Powered by Yahoo! Finance |
I had to request it. No hard pull involved!
Report Your "Credit limit...